These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 23609215)
1. Manganese-induced Parkinsonism among ephedrone users and drug policy in Poland. Fudalej S; Kołodziejczyk I; Gajda T; Majkowska-Zwolińska B; Wojnar M J Addict Med; 2013; 7(4):302-3. PubMed ID: 23609215 [TBL] [Abstract][Full Text] [Related]
2. Irreversible motor impairment in young addicts--ephedrone, manganism or both? Sikk K; Taba P; Haldre S; Bergquist J; Nyholm D; Zjablov G; Asser T; Aquilonius SM Acta Neurol Scand; 2007 Jun; 115(6):385-9. PubMed ID: 17511846 [TBL] [Abstract][Full Text] [Related]
3. Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse. de Bie RM; Gladstone RM; Strafella AP; Ko JH; Lang AE Arch Neurol; 2007 Jun; 64(6):886-9. PubMed ID: 17562938 [TBL] [Abstract][Full Text] [Related]
4. [Encephalopathy caused by intravenous potassium permanganate used for illegal production of methcathinone (ephedrone) from medicines containing pseudoephedrine]. Habrat B; Baran-Furga H; Sienkiewicz-Jarosz H; Sein Anand J; Poniatowska R Przegl Lek; 2013; 70(8):613-6. PubMed ID: 24466704 [TBL] [Abstract][Full Text] [Related]
5. Parkinsonism and dystonia caused by the illicit use of ephedrone--a longitudinal study. Selikhova M; Fedoryshyn L; Matviyenko Y; Komnatska I; Kyrylchuk M; Krolicki L; Friedman A; Taylor A; Jäger HR; Lees A; Sanotsky Y Mov Disord; 2008 Nov; 23(15):2224-31. PubMed ID: 18785245 [TBL] [Abstract][Full Text] [Related]